
Guardian Bio YC 申请
Guardian Bio 在 Summer 2022 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Summer 2022
- 行业
- HealthcareTherapeutics
- 团队规模
- 2
- 状态
- Active
- 已发布
- 2022
创始人
Ananya ZutshiFounder
Ricky BarrettFounder
Guardian Bio 做什么
Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.
Guardian Bio 的 YC 申请,重建版
Y Combinator 申请
Guardian Bio,Summer 2022 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Guardian Bio
Dendritic cell-based platform for cancer therapy
We create a dendritic cell therapy for cancer patients. Our product takes stem cells from a patient, turns them into therapeutic dendritic cells trained to recognize that patient's tumor, and puts them back to activate the immune system to fight cancer.
We currently live in Boston, MA, and the company will be based there after YC as well.
Boston is a hub for biotech and medical research with access to leading hospitals and academic collaborators, which is critical for our work developing cellular therapies.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 Guardian Bio 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 Guardian Bio 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Guardian Bio 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
Guardian Bio 是哪个 YC 批次的?
Guardian Bio 是 Y Combinator Summer 2022 批次的成员。
谁创立了 Guardian Bio?
Guardian Bio 由 Ananya Zutshi, Ricky Barrett 创立。
Guardian Bio 做什么?
Dendritic cell-based platform for cancer therapy
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 Guardian Bio 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。